These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 36204804)

  • 1. Practice guidelines for the management of
    Alsohaibani F; Peedikayil M; Alshahrani A; Somily A; Alsulaiman R; Azzam N; Almadi M
    Saudi J Gastroenterol; 2023; 29(6):326-346. PubMed ID: 36204804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The second Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of Helicobacter pylori infection in adult patients in Ireland.
    Smith SM; Boyle B; Buckley M; Costigan C; Doyle M; Farrell R; Ismail MS; Kevans D; Nugent S; O'Connor A; O'Morain C; Parihar V; Ryan C; McNamara D
    Eur J Gastroenterol Hepatol; 2024 Aug; 36(8):1000-1009. PubMed ID: 38829956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of H. pylori infection in adult patients in Ireland.
    Smith S; Boyle B; Brennan D; Buckley M; Crotty P; Doyle M; Farrell R; Hussey M; Kevans D; Malfertheiner P; Megraud F; Nugent S; O'Connor A; O'Morain C; Weston S; McNamara D
    Eur J Gastroenterol Hepatol; 2017 May; 29(5):552-559. PubMed ID: 28350745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults.
    Fallone CA; Chiba N; van Zanten SV; Fischbach L; Gisbert JP; Hunt RH; Jones NL; Render C; Leontiadis GI; Moayyedi P; Marshall JK
    Gastroenterology; 2016 Jul; 151(1):51-69.e14. PubMed ID: 27102658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel and Effective Therapeutic Regimens for
    Hu Y; Zhu Y; Lu NH
    Front Cell Infect Microbiol; 2017; 7():168. PubMed ID: 28529929
    [No Abstract]   [Full Text] [Related]  

  • 6. Reconciliation of Recent Helicobacter pylori Treatment Guidelines in a Time of Increasing Resistance to Antibiotics.
    Fallone CA; Moss SF; Malfertheiner P
    Gastroenterology; 2019 Jul; 157(1):44-53. PubMed ID: 30998990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Helicobacter pylori-associated diseases].
    Gisbert JP
    Gastroenterol Hepatol; 2015 Sep; 38 Suppl 1():39-48. PubMed ID: 26520195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second-line rescue treatment of
    Lin TF; Hsu PI
    World J Gastroenterol; 2018 Oct; 24(40):4548-4553. PubMed ID: 30386104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding treatment guidelines with bismuth and non-bismuth quadruple Helicobacter pylori eradication therapies.
    Graham DY; Dore MP; Lu H
    Expert Rev Anti Infect Ther; 2018 Sep; 16(9):679-687. PubMed ID: 30102559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new look at anti-Helicobacter pylori therapy.
    Chuah SK; Tsay FW; Hsu PI; Wu DC
    World J Gastroenterol; 2011 Sep; 17(35):3971-5. PubMed ID: 22046084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective trial in Saudi Arabia comparing the 14-day standard triple therapy with the 10-day sequential therapy for treatment of Helicobacter pylori infection.
    Alsohaibani F; Al Ashgar H; Al Kahtani K; Kagevi I; Peedikayil M; Alfadda A; Khan M
    Saudi J Gastroenterol; 2015; 21(4):220-5. PubMed ID: 26228365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a bismuth-based quadruple therapy regimen for
    Alsohaibani F; Alquaiz M; Alkahtani K; Alashgar H; Peedikayil M; AlFadda A; Almadi M
    Saudi J Gastroenterol; 2020; 26(2):84-88. PubMed ID: 32295933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of second-line regimens for
    Chang YL; Tung YC; Tu YK; Yeh HZ; Yang JC; Hsu PI; Kim SE; Wu MF; Liou WS; Shiu SI
    BMJ Open Gastroenterol; 2020 Sep; 7(1):. PubMed ID: 32883715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimum duration of regimens for Helicobacter pylori eradication.
    Yuan Y; Ford AC; Khan KJ; Gisbert JP; Forman D; Leontiadis GI; Tse F; Calvet X; Fallone C; Fischbach L; Oderda G; Bazzoli F; Moayyedi P
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008337. PubMed ID: 24338763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world practice of Helicobacter pylori management: A survey among physicians in Southeast Asia.
    Quach DT; Vilaichone RK; Luu MN; Lee YY; Ang TL; Miftahussurur M; Aye TT; Basir DN; Vutha K; Vannarath S; Sollano JD; Mahachai V
    Helicobacter; 2023 Dec; 28(6):e13018. PubMed ID: 37634226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of four different regimens against Helicobacter pylori as a first-line treatment: A prospective, cross-sectional, comparative, open trial in Chinese children.
    Zhou Y; Ye Z; Wang Y; Zhang Y; Tang Z; Yan W; Jiang Y; Huang Y
    Helicobacter; 2020 Apr; 25(2):e12679. PubMed ID: 31958193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori Eradication Rates in Slovenia in the Period from 2017 to 2019: Data from the European Registry on H. pylori Management.
    Tepes B; Brglez Jurecic N; Tepes K; Espada Sanchez M; Perez Nyssen O; O'Morain C; Mégraud F; Gisbert J
    Dig Dis; 2021; 39(4):318-324. PubMed ID: 33099549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy.
    Song Z; Zhou L; Zhang J; He L; Bai P; Xue Y
    Dig Liver Dis; 2016 May; 48(5):506-511. PubMed ID: 26847964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
    Lee HJ; Kim JI; Lee JS; Jun EJ; Oh JH; Cheung DY; Chung WC; Kim BW; Kim SS
    World J Gastroenterol; 2015 Jan; 21(1):351-9. PubMed ID: 25574111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to international guidelines for the management of Helicobacter pylori infection among gastroenterologists and gastroenterology fellows in Italy: A Survey of the Italian Federation of Digestive Diseases - FISMAD.
    Zagari RM; Romano M; Frazzoni L; Marasco G; Dajti E; Arcidiacono PG; Armuzzi A; Biagi F; Cannizzaro R; Cavestro GM; Ciacci C; Monica F; Peralta S; Radaelli F; Bazzoli F
    Helicobacter; 2022 Feb; 27(1):e12862. PubMed ID: 34766392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.